Aventis Taxotere Approved For Breast Cancer; Lowers Relapse Chance 25.7%

 
• By The Pink Sheet

Aventis added an adjuvant node-positive breast cancer indication for Taxotere Aug. 18

More from Archive

More from Pink Sheet